|
Earnings
| ShowHide Related Items >><< - 07/19/22
- Katapult hires Bork as new Chief Revenue Officer
- 06/07/22
- Katapult CEO buys $200K in common stock
- 03/28/22
- Infinitum urges Katapult board to commence full strategic review
- 03/23/22
- Katapult Adyen hires new VP of Strategic Partnerships, VP of Strategy
- 05/11/22 Loop Capital
- Katapult downgraded to Hold from Buy at Loop Capital
- 10/05/21 Cantor Fitzgerald
- Katapult initiated with a Neutral at Cantor Fitzgerald
- 09/03/21 KeyBanc
- Katapult well positioned to benefit from new partnerships, says KeyBanc
- 08/12/21 Loop Capital
- Katapult price target lowered to $7 from $12 at Loop Capital
- 05/10/22
- Katapult reports Q1 EPS (6c) vs 15c last year
- 03/15/22
- Katapult reports Q4 revenue 7c, one est. (6c)
- 02/14/22
- Largest borrow rate increases among liquid names
|
|
Upgrade
| ShowHide Related Items >><< - 07/25/22
- Tim China announces collaboration with Easy Joy
- 07/25/22
- Kitchen United announces $100M Series C fundraise
- 05/16/22
- Pershing Square boosts Canadian Pacific, cuts Domino's in Q1
- 05/05/22
- Regis names Matthew Doctor as CEO
- 08/05/22 Baird
- Restaurant Brands price target raised to $63 from $56 at Baird
- 08/05/22 Deutsche Bank
- Restaurant Brands price target raised to $70 from $64 at Deutsche Bank
- 07/18/22 Morgan Stanley
- Restaurant Brands price target lowered to $52 from $56 at Morgan Stanley
- 07/11/22 Deutsche Bank
- Restaurant Brands price target lowered to $64 from $70 at Deutsche Bank
- 08/04/22
- Restaurant Brands reports Q2 EPS 76c, consensus 73c
- 05/03/22
- Restaurant Brands reports Q1 adjusted EPS 64c, consensus 62c
- 02/15/22
- Restaurant Brands reports Q4 EPS 74c, consensus 69c
- 02/14/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- What You Missed On Wall Street On Thursday
- 08/04/22
- What You Missed On Wall Street This Morning
- 08/04/22
- Fly Intel: Pre-market Movers
- 05/04/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Hot Stocks
| ShowHide Related Items >><< - 07:11 Today
- Axsome Therapeutics expects cash to fund operations into 2024
- 06/27/22
- Axsome Therapeutics reports receipt from FDA of proposed AXS-05 labeling
- 06/06/22
- Axsome Therapeutics announces results of SUPPORT survey of MDD patients
- 06/02/22
- Axsome Therapeutics presents new data from GEMINI trial on AXS-05
- 07/08/22 Morgan Stanley
- Axsome Therapeutics price target raised to $54 from $27 at Morgan Stanley
- 06/29/22 Cowen
- Axsome Therapeutics price target raised to $130 from $120 at Cowen
- 06/29/22 Cantor Fitzgerald
- Axsome Therapeutics price target raised to $64 from $47 at Cantor Fitzgerald
- 05/06/22 Morgan Stanley
- Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news
- 07:11 Today
- Axsome Therapeutics reports Q2 EPS ($1.06), consensus ($1.24)
- 05/02/22
- Axsome Therapeutics reports Q1 EPS ($1.03) with items, consensus (10c)
- 03/01/22
- Axsome Therapeutics reports Q4 EPS (90c), consensus ($1.03)
- 06/27/22
- What You Missed On Wall Street On Monday
- 06/27/22
- Fly Intel: Pre-market Movers
- 04/25/22
- What You Missed On Wall Street On Monday
- 04/25/22
- What You Missed On Wall Street This Morning
- 07/28/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 07/12/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 06/24/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 06/23/22
- Axsome Therapeutics call volume above normal and directionally bullish
|
|
Downgrade
| ShowHide Related Items >><< - 07/29/22
- Charter sees FY22 cable CapEx $7.1B-$7.3B
- 07/29/22
- Charter: Q2 total residential, SMB mobile lines up 344,000
- 06/15/22
- Charter CFO sees removal of around 60K-70K broadband customers on subsidy change
- 05/12/22
- Marcien Jenckes named president of Comcast, Charter joint venture
- 08/01/22 Morgan Stanley
- Charter price target lowered to $550 from $600 at Morgan Stanley
- 08/01/22 Deutsche Bank
- Charter price target lowered to $550 from $575 at Deutsche Bank
- 08/01/22 Barclays
- Charter downgraded to Underweight from Equal Weight at Barclays
- 08/01/22 Pivotal Research
- Charter price target lowered to $560 from $585 at Pivotal Research
- 07/29/22
- Charter reports Q2 EPS $8.80, consensus $6.89
- 07/28/22
- Notable companies reporting before tomorrow's open
- 07/28/22
- Notable companies reporting before tomorrow's open
- 04/29/22
- Charter reports Q1 EPS $6.90, consensus $6.47
- 08/04/22
- Altice USA targeting PE funds in early Suddenlink negotiations, CNBC says
- 08/03/22
- WideOpenWest, Suddenlink in talks with potential buyers, CNBC reports
- 07/27/22
- Charter found liable for $7B in punitive damages for 2019 murder, WSJ reports
- 08/01/22
- What You Missed On Wall Street On Monday
- 08/01/22
- What You Missed On Wall Street This Morning
- 08/01/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/01/22
- Fly Intel: Pre-market Movers
- 05/09/22
- Early notable gainers among liquid option names on May 9th
- 03/03/22
- Early notable gainers among liquid option names on March 3rd
|
|
Recommendations
| ShowHide Related Items >><< - 03/30/22
- Lundin Mining reports fatality at Neves-Corvo Mine
- 07/29/22 UBS
- Lundin Mining price target lowered to SEK 60 from SEK 65 at UBS
- 07/29/22 Deutsche Bank
- Lundin Mining price target lowered to SEK 65 from SEK 75 at Deutsche Bank
- 07/29/22 Canaccord
- Lundin Mining price target lowered to C$10.50 from C$11.50 at Canaccord
- 07/29/22 RBC Capital
- Lundin Mining price target lowered to C$10 from C$14 at RBC Capital
- 04/29/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Hot Stocks
|
Cash and cash equivalents… ShowHide Related Items >><< ACHL Achilles Therapeutics - 07/25/22
- Point72 reports 5.3% passive stake in Achilles Therapeutics
- 07/21/22
- Achilles Therapeutics to lead Horizon Europe-funded consortium
- 06/30/22
- Achilles Therapeutics appoints Taylo as CBO, Yee to SAB
- 05/10/22
- Achilles Therapeutics expects cash to fund operations into 2H of 2024
ACHL Achilles Therapeutics - 05/27/22 Piper Sandler
- Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
- 05/10/22 Piper Sandler
- Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
- 03/01/22 Piper Sandler
- Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
- 11/12/21 Piper Sandler
- Achilles provides clinical update for ATL001 trials, says Piper Sandler
ACHL Achilles Therapeutics - 07:11 Today
- Achilles Therapeutics reports Q2 EPS (44c), consensus (56c)
- 05/10/22
- Achilles Therapeutics reports Q1 EPS (45c), consensus (50c)
- 03/01/22
- Achilles Therapeutics reports Q4 EPS (45c), consensus (41c)
|
|
Earnings
| ShowHide Related Items >><< - 07/26/22
- Novanta to replace Six Flags in the S&P 400 at open on 7/26
- 07/26/22
- Six Flags to replace Natus Medical in the S&P 600 at open on 7/26
- 07/21/22
- Six Flags to replace Natus Medical in the S&P 600 at open on 7/26
- 07/21/22
- Novanta to replace Six Flags in the S&P 400 at open on 7/26
- 06/08/22
- Baird to hold a conference
- 06/07/22
- Baird to hold a conference
- 05/11/22 William Blair
- Novanta upgraded to Outperform after 35% pullback at William Blair
- 05/11/22 William Blair
- Novanta upgraded to Outperform from Market Perform at William Blair
- 07:09 Today
- Novanta sees Q3 adjusted EPS 71c-76c, consensus 77c
- 07:08 Today
- Novanta reports Q2 adjusted EPS 78c, consensus 72c
- 05/10/22
- Novanta sees Q2 adjusted EPS 69c-73c, consensus 72c
- 05/10/22
- Novanta reports Q1 adjusted EPS 73c, consensus 63c
- 07/21/22
- Fly Intel: After-Hours Movers
|
|
Hot Stocks
|
Axsome believes that its… ShowHide Related Items >><< - 06/27/22
- Axsome Therapeutics reports receipt from FDA of proposed AXS-05 labeling
- 06/06/22
- Axsome Therapeutics announces results of SUPPORT survey of MDD patients
- 06/02/22
- Axsome Therapeutics presents new data from GEMINI trial on AXS-05
- 06/01/22
- Axsome reports rapid, substantial improvement in MADRS, SDS with AXS-05
- 07/08/22 Morgan Stanley
- Axsome Therapeutics price target raised to $54 from $27 at Morgan Stanley
- 06/29/22 Cowen
- Axsome Therapeutics price target raised to $130 from $120 at Cowen
- 06/29/22 Cantor Fitzgerald
- Axsome Therapeutics price target raised to $64 from $47 at Cantor Fitzgerald
- 05/06/22 Morgan Stanley
- Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news
- 07:11 Today
- Axsome Therapeutics reports Q2 EPS ($1.06), consensus ($1.24)
- 05/02/22
- Axsome Therapeutics reports Q1 EPS ($1.03) with items, consensus (10c)
- 03/01/22
- Axsome Therapeutics reports Q4 EPS (90c), consensus ($1.03)
- 06/27/22
- What You Missed On Wall Street On Monday
- 06/27/22
- Fly Intel: Pre-market Movers
- 04/25/22
- What You Missed On Wall Street On Monday
- 04/25/22
- What You Missed On Wall Street This Morning
- 07/28/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 07/12/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 06/24/22
- Axsome Therapeutics put volume heavy and directionally bearish
- 06/23/22
- Axsome Therapeutics call volume above normal and directionally bullish
|
|
Earnings
| ShowHide Related Items >><< ACHL Achilles Therapeutics - 07/25/22
- Point72 reports 5.3% passive stake in Achilles Therapeutics
- 07/21/22
- Achilles Therapeutics to lead Horizon Europe-funded consortium
- 06/30/22
- Achilles Therapeutics appoints Taylo as CBO, Yee to SAB
- 05/10/22
- Achilles Therapeutics expects cash to fund operations into 2H of 2024
ACHL Achilles Therapeutics - 05/27/22 Piper Sandler
- Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
- 05/10/22 Piper Sandler
- Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
- 03/01/22 Piper Sandler
- Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
- 11/12/21 Piper Sandler
- Achilles provides clinical update for ATL001 trials, says Piper Sandler
ACHL Achilles Therapeutics - 05/10/22
- Achilles Therapeutics reports Q1 EPS (45c), consensus (50c)
- 03/01/22
- Achilles Therapeutics reports Q4 EPS (45c), consensus (41c)
|
|
Hot Stocks
| ShowHide Related Items >><< - 08/08/22
- FedEx Freight announces door count increase
- 08/02/22
- Berkshire Grey, FedEx expand robotic automation solutions relationship
- 06/30/22
- Xos delivers three battery-electric stepvans to FedEx Ground Operator
- 06/29/22
- FedEx sees adjusted free cash flow 'north of $4B' in 2023
- 08/03/22
- Ford reports July U.S. sales up 36.6% y/y to 163,942 vehicles
- 07/27/22
- Ford says semiconductors still an issue
- 07/27/22
- Ford says operations are too complex
- 07/27/22
- Ford says increasing dividend to 15c per share
- 08/02/22 Craig-Hallum
- Berkshire Grey pact with FedEx 'significant catalyst,' says Craig-Hallum
- 07/01/22 Berenberg
- FedEx downgraded to Hold from Buy at Berenberg
- 06/30/22 BofA
- FedEx price target raised to $287 from $276 at BofA
- 06/30/22 KeyBanc
- FedEx price target raised to $325 from $300 at KeyBanc
- 08/02/22 Citi
- Citi ticks up Ford target, closes 'Upside Catalyst Watch'
- 08/01/22 Benchmark
- Ford price target lowered to $23 from $25 at Benchmark
- 07/28/22 Deutsche Bank
- Ford price target raised to $13 from $12 at Deutsche Bank
- 07/26/22 JPMorgan
- Ford price target lowered to $19 from $21 at JPMorgan
- 06/23/22
- FedEx sees FY23 EPS ex-items $22.50-$24.50, consensus $22.41
- 06/23/22
- FedEx reports Q4 adjusted EPS $6.87, consensus $6.88
- 06/23/22
- Notable companies reporting after market close
- 03/17/22
- FedEx sees FY22 adjusted EPS 18.60-$19.60, consensus $20.61
- 07/27/22
- Ford reports Q2 adjusted EPS 68c, consensus 45c
- 07/27/22
- Notable companies reporting after market close
- 06/28/22
- InterDigital raises Q2 revenue view to $120M-$124M from $114M-$120M
- 04/27/22
- Ford reports Q1 adjusted EPS 38c, consensus 37c
- 07/22/22
- FedEx to suspend some Sunday deliveries, WSJ reports
- 06/21/22
- FedEx investing in freight-tracking software company FourKites, WSJ reports
- 04/16/22
- New CEO, ground business push could help FedEx catch up to rival, Barron's says
- 03/29/22
- FedEx CEO change won't deter potential activism, CNBC's Faber says
- 08/07/22
- Tata Motors agrees to buy Ford's Gujarat plant for $92M, Bloomberg says
- 07/26/22
- NHTSA investigating over 1.8M Stellantis, Ford, GM vehicles, Reuters reports
- 07/26/22
- NHTSA probes Ford Bronco over reports of engine failure, WSJ reports
- 07/20/22
- Ford intends to cut as many as 8,000 positions in coming weeks, Bloomberg says
- 08/02/22
- What You Missed On Wall Street On Tuesday
- 08/02/22
- What You Missed On Wall Street This Morning
- 07/22/22
- What You Missed On Wall Street On Friday
- 07/22/22
- What You Missed On Wall Street This Morning
- 07/28/22
- What You Missed On Wall Street On Thursday
- 07/28/22
- What You Missed On Wall Street This Morning
- 07/28/22
- Fly Intel: Pre-market Movers
- 07/27/22
- Fly Intel: After-Hours Movers
- 06/24/22
- Early notable gainers among liquid option names on June 24th
- 06/23/22
- Fedex options imply 6.2% move in share price post-earnings
- 06/14/22
- Early notable gainers among liquid option names on June 14th
- 06/14/22
- Unusually active option classes on open June 14th
- 08/08/22
- Notable open interest changes for August 8th
- 08/03/22
- Unusually active option classes on open August 3rd
- 08/02/22
- Notable open interest changes for August 2nd
- 08/01/22
- Ford call volume above normal and directionally bullish
|
